MedPath

Implementation of a Self-Help Depression Program Among Orthopedic Patients

Not Applicable
Withdrawn
Conditions
MDD
Interventions
Behavioral: Deprexis
Registration Number
NCT03083340
Lead Sponsor
University of Texas at Austin
Brief Summary

The proposed study addresses the potential utility of providing an accessible self-help intervention for patients in a medical setting with an estimated diagnosis of MDD. Specifically, the study will explore whether a) such an intervention can be effectively implemented in a primary care setting and b) patients originally seeking medical attention for an orthopedic problem will be willing to seek psychological treatment and, c) improvement in depression symptoms will lead to improvement in upper and lower extremity functioning.

Detailed Description

The present project will be an open-label trial to assess the feasibility and acceptability of a self-help intervention among a sample of orthopedic patients. In addition to monitoring the effectiveness of the Deprexis program on depressive symptoms, the proposed project will assess whether a reduction in depressive symptoms will be associated with improvement on patient reported orthopedic impairment. The investigators will enroll 50 adults and the participants will be given the opportunity to participate in 8 weeks of the web-based online Deprexis program.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • All patients older than 18 years who present to a surgeon with an upper or lower extremity injury or disability at a participating center (see attached list)
  • A level of clinical depression more than minimal symptoms as defined by a score ≥ 10 on the Patient Health Questionnaire-9 (PHQ-9)
  • Willing and able to provide informed consent and comply with the protocol
Exclusion Criteria
  • Injury or illness best treated with prompt surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
DeprexisDeprexisParticipants will complete 8 weeks of online treatment via a web-based program, Deprexis.
Primary Outcome Measures
NameTimeMethod
Proof of Concept - Acceptability measured by number of modules completed on the online program8 Weeks

The primary outcome will be the level of acceptability of the intervention as measured by number of completed modules on the online Deprexis program.

Proof of Concept - Acceptability measured by number of eligible participants that choose to participate8 weeks

The primary outcome will be the level of acceptability of the intervention as measured by the number of eligible participants who chose to participate in the intervention.

Proof of Concept - Acceptability measured by qualitative feedback8 Weeks

The primary outcome will be the level of acceptability of the intervention as measured by qualitative feedback following the intervention created by the investigators on how acceptable the study was for the participant.

Proof of Concept - Feasibility measured by qualitative feedback8 Weeks

The primary outcome will be the level of acceptability of the intervention as measured by qualitative feedback following the intervention created by the investigators on how acceptable the study was for the participant.

Proof of Concept - Feasibility measured by number of eligible participants that choose to participate8 Weeks

The primary outcome will be the level of feasibility of the intervention as measured by he number of eligible participants who chose to participate in the intervention.

Proof of Concept - Feasibility measured by number of modules completed on the online program8 Weeks

The primary outcome will be the level of acceptability of the intervention as measured by number of completed modules on the online Deprexis program.

Secondary Outcome Measures
NameTimeMethod
Level of Improvement of Depression (by scores on the PHQ-9)8 weeks

Secondary outcome measures will be the level of depressive symptoms as evidenced by scores on the PHQ-9.

Level of Improvement of Functioning (by scores on the PROMIS Physical Function CAT)8 weeks

Secondary outcome measure will be the level of improvement in upper and lower extremity function as measured by scores on the PROMIS Physical Function CAT.

Trial Locations

Locations (1)

University of Texas at Austin

🇺🇸

Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath